Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd News Today

2,600
(0.52%)
Dec 9, 2024|10:09:54 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Company

Sectoral

Mankind Pharma Sees 30% Profit Surge in Q2

Revenue from operations grew by 13.6% YoY, totaling ₹3,076.5 Crore, up from ₹2,708.1 Crore in Q2 of the previous fiscal.

6 Nov 2024|10:12 PM
Top stocks for today - 6th November 2024

Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.

6 Nov 2024|08:08 AM
Top stocks for today - 24th October 2024

Here are some of the stocks that may see significant price movement today: Escorts Kubota, Infosys, Mahindra & Mahindra, etc.

24 Oct 2024|08:15 AM
CCI greenlights Mankind Pharma's Rs 13,630 crore takeover of Bharat Serums

Mankind announced in July that it would purchase the whole stake in Bharat Serums and Vaccines.

3 Oct 2024|11:02 AM
Top 10 stocks for today – 3rd October 2024

Here are some of the stocks that may see significant price movement today: Suzlon Energy, Aurobindo Pharma, Coal India, etc.

3 Oct 2024|09:07 AM
Top 10 stocks for today – 1st October 2024

Here are some of the stocks that may see significant price movement today: Tata Power, India Glycols, Jindal Stainless, etc.

1 Oct 2024|08:17 AM
Mankind Pharma board approves ₹10,000 Crore fund raise

The company will offer commercial papers on the BSE in numerous tranches ranging from three to twelve months

30 Sep 2024|07:41 PM
Mankind Pharma Announces NCD Fundraising Initiative

This strategic move is intended to streamline Mankind Pharma’s operations, enabling greater focus on its core pharmaceutical business.

23 Sep 2024|01:56 PM
Mankind Pharma Transfers OTC Business to Subsidiary in Strategic Realignment

The transfer is in line with Mankind Pharma's previously announced strategy on April 2, aiming to enhance operational efficiency by consolidating the OTC business under MCPPL.

4 Sep 2024|10:21 AM
Mankind Pharma targets ₹9,000 crore debt for BSV deal

When the acquisition was announced, the business stated that it will be paid by internal accruals as well as a combination of debt and stock.

3 Sep 2024|12:25 PM
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp